Global remote patient monitoring devices market estimated to reach USD 1.2 billion by 2022
According to a report published by Radiant Insights, the global remote patient monitoring devices market is estimated to reach USD 1.2 billion by 2022. Latin American and Asian geographies are likely to drive the market growth. Since the remote patient monitoring devices can monitor various chronic ailments such as diabetes, cardiovascular disorders and cancer, therefore, they are expected to see significant growth over the forecast period. The paramount aspects contributing to the market growth include increasing geriatric population base, rising number of cases of cardiovascular diseases, desire of independent & healthy living, reforming healthcare infrastructure, post-acute care management and demand in the developing regions of Asia Pacific and Latin America. Heart rate monitors are recognized as the most profitable sub-sector due to increasing cases of cardiac conditions worldwide. North America had led the remote patient monitoring devices market in 2014, by capturing more than 40% of the market. China and India are identified as the most beneficial regions of the Asian market owing to government’s support to restrict the decaying environmental conditions and reforming healthcare infrastructure in Japan and Australia are also expected to contribute to this market’s lucrativeness. Philips, Honeywell, American Telecare, Roche, Philips Healthcare, Bosch, Biotronik, Intel, Welch Allyn, Healthanywhere, Johnson & Johnson and Covidien are the major market players.
(Image Courtesy: pixcooler)
Read the full article at medGadget